Literature DB >> 10441498

Characterization of a novel member of the FGF family, XFGF-20, in Xenopus laevis.

C Koga1, N Adati, K Nakata, K Mikoshiba, Y Furuhata, S Sato, H Tei, Y Sakaki, T Kurokawa, K Shiokawa, K K Yokoyama.   

Abstract

The cDNA for a novel member of the FGF family (XFGF-20) was isolated from a Xenopus cDNA library prepared at the tailbud stage using as a probe the product of degenerate PCR performed with primers based on mammalian FGF-9s. This cDNA was 1860 bp long, and contained a single open reading frame that encoded 208 amino acid residues. The deduced amino acid sequence contained a motif characteristic of the FGF family and it was similar (73.1% overall homology) to XFGF-9 but differed from XFGF-9 in its amino-terminal region (33.3% homology). XFGF-20 mRNA was expressed only zygotically in embryos at and after the blastula stage, but it was also specifically expressed in the stomach and testis of adults. By contrast, XFGF-9 mRNA was expressed maternally in eggs and in many adult tissues. When XFGF-20 mRNA was overexpressed in early embryos, gastrulation was abnormal and development of anterior structures was suppressed. In such embryos, the expression of the Xbra transcript was suppressed during gastrulation while the expression of the transcripts of cerberus, Siamois, dkk-1, chordin, and Xotx-2 genes was normal. These results suggest that correct expression of XFGF-20 during gastrulation is required for the formation of normal head structures in Xenopus laevis during embryogenesis and that expression of the Xbra gene mediates this phenomenon. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441498     DOI: 10.1006/bbrc.1999.1039

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas.

Authors:  S La Rosa; F Sessa; L Colombo; M G Tibiletti; D Furlan; C Capella
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development.

Authors:  Mario N Chamorro; Donald R Schwartz; Alin Vonica; Ali H Brivanlou; Kathleen R Cho; Harold E Varmus
Journal:  EMBO J       Date:  2004-12-09       Impact factor: 11.598

3.  Long-term results and safety of fibroblast growth factor injection for unilateral vocal fold paralysis.

Authors:  Tomohiko Yamauchi; Takeharu Kanazawa; Tomohiro Hasegawa; Kazuya Kurakami; Ujimoto Konomi; Mayu Hirosaki; Daigo Komazawa; Miki Nozawa; Satoka Takahashi; Yusuke Watanabe
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-05-25

4.  Temporal and spatial expression of FGF ligands and receptors during Xenopus development.

Authors:  Robert Lea; Nancy Papalopulu; Enrique Amaya; Karel Dorey
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

Review 5.  Genetics of vesicoureteral reflux and congenital anomalies of the kidney and urinary tract.

Authors:  Keum Hwa Lee; Heon Yung Gee; Jae Il Shin
Journal:  Investig Clin Urol       Date:  2017-06-07

6.  Paracrine influence of human perivascular cells on the proliferation of adenocarcinoma alveolar epithelial cells.

Authors:  Eunbi Kim; Sunghun Na; Borim An; Se-Ran Yang; Woo Jin Kim; Kwon-Soo Ha; Eun-Taek Han; Won Sun Park; Chang-Min Lee; Ji Yoon Lee; Seung-Joon Lee; Seok-Ho Hong
Journal:  Korean J Physiol Pharmacol       Date:  2017-02-21       Impact factor: 2.016

7.  Fibroblast growth factor 20 attenuates pathological cardiac hypertrophy by activating the SIRT1 signaling pathway.

Authors:  Yunjie Chen; Ning An; Xuan Zhou; Lin Mei; Yanru Sui; Gen Chen; Huinan Chen; Shengqu He; Cheng Jin; Zhicheng Hu; Wanqian Li; Yang Wang; Zhu Lin; Peng Chen; Litai Jin; Xueqiang Guan; Xu Wang
Journal:  Cell Death Dis       Date:  2022-03-28       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.